Caligan Partners in the Press
March 7, 2024 - Caligan discloses 9.7% stake in anika Therapeutics (ANIK) and nominates 2 director candidates
June 1, 2023 - Farallon and caligan Win Proxy Contest at exelixis (exel) - Caligan’s david johnson to join the board effective immediately
May 17, 2023 - Caligan leads preferred equity pipe into alimera sciences (ALIM) to facilitate the purchase of the u.s. rights to yutiq from eyepoint pharmaceuticals (eypt)
Apr 13, 2023 - ANIKA SETTLES WITH CALIGAN PARTNERS, REFRESHES BOARD AND AGREES TO STOCK BUYBACK PLAN
feb 21, 2023 - Caligan partners letter to the board of anika therapeutics (anik)